New challenges in regenerative medicine: aesthetic correction Ozempic Face
From local facial aesthetics to a systemic medical approach
Rehabilitation2026-02-06
The aesthetic medicine industry has entered the era of “GLP-1 patients.” The triumphant popularity of glucagon-like peptide-1 receptor agonists has changed not only endocrinology, but also the face of modern cosmetology – literally. Rapid weight loss forms a specific morphotype, known as the Ozempic Face, which requires fundamentally new work algorithms from the doctor.